Argus Research analyst Jasper Hellweg maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) yesterday. The company’s shares ...
Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $28.00.
Hosted on MSN9mon
The Complete Buyer’s Guide to Teva: Supportive Sandals, Hiking Sneakers, and More Editor-Loved Shoes"“While Teva’s heritage is in the outdoors, we don’t define what the outdoors means to our consumer.” — Jess Bensley" $65 Buy on Amazon $70 Buy on teva.com Some of the most comfortable ...
BofA Securities made adjustments to its financial model for Teva Pharmaceutical Industries Ltd (NYSE:TEVA), resulting in a lowered price target. While the firm maintained a Buy rating on the stock, ...
Technical analysis for Teva Pharmaceutical Industries Limited American Depositary Shares TEVA including support levels resistance levels and stop losses for TEVA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback